Investigação sobre adesão à terapêutica na população portuguesa: uma revisão de âmbito

Coelho, André; Vilares, Cláudia; Silva, Mariana; Rodrigues, Catarina; Costa, Marta Miriam Lopes; Gordicho, Sara; Caetano, Pedro A.

doi:10.32385/rpmgf.v33i4.12226

Cited by 2 publications

(6 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first hypothesis would point out the need for health education strategies, since, considering that HT and DM can be asymptomatic or little symptomatic, patients often have little understanding of their risk or the relevance of regular use of medications to control these conditions (Osterberg, & Blaschke, 2005). The complexity of continuous pharmacotherapeutic regimes such as these diseases' can also contribute to hinder treatment adherence (Coleman et al, 2012;Coelho et al, 2017), as well as the number of drugs prescribed and the adverse effects resulting from their use. Failing to properly follow up or abandoning prescriptions leads to increase in the number of hospitalizations and treatment costs, decrease in effectiveness, loss of quality of life and less productivity for the country (Lessa, 2006).…”

Section: Discussionmentioning

confidence: 99%

Potential drug therapy problems: identification and associated factors among Primary Health Care users

Gualberto

Valentin

Oliveira

et al. 2021

RSD

View full text Add to dashboard Cite

Cardiovascular diseases (CVD) and diabetes mellitus (DM) are chronic non-communicable diseases with high prevalence. Several factors contribute to its lack of control, especially those related to pharmacotherapy, often leading to problems related to the use of medication (DTP). Objective: To identify potential DTPs for the treatment of CVD and DM, as well as associated factors, using big data from users of the Unified Health System (SUS) in a municipality. Methods: A cross-sectional study was carried out based on big data of patients for whom at least one medication was dispensed in SUS pharmacies in the primary healthcare network in April 2019 (n = 4,800). Potential DTPs involving the treatment of CVD or DM were identified based on data on medications dispensed, demographic and clinical characteristics. To classify these potential PRMs, the Pharmacotherapy Workup method was used. Logistic regression analyzes were performed to identify factors associated with identifying at least one potential MRP. Results: The results showed that 25% of the population had at least one potential DTP, with a total of 1,914 potential PRMs being identified. In the multivariate model, age group was statistically associated with the identification of at least one potential DTP. Conclusions: This study allows tracing the frequency of important potential DTPs and associated factors, pointing out some priorities that must be addressed by the public primary health care system, supporting the planning of the implementation of drug therapy management services aimed at the studied population.

show abstract

Section: Discussionmentioning

confidence: 99%

Potential drug therapy problems: identification and associated factors among Primary Health Care users

Gualberto

Valentin

Oliveira

et al. 2021

RSD

View full text Add to dashboard Cite

show abstract

“…This percentage is lower in developing countries, which seriously harms individual and global health (WHO, 2003). The global economic impact caused by these diseases is expected to account for 65% of global health care costs, causing strong worldwide public health concerns as this impact is frequent, widespread, and independent of the therapeutic area (Coelho et al, 2017;Kini & Ho, 2018;WHO, 2003). Since the 1970s, the literature on TA and non-adherence rates has shown great variability, demonstrating difficulties in collecting accurate information.…”

Section: Introductionmentioning

confidence: 99%

“…Since the 1970s, the literature on TA and non-adherence rates has shown great variability, demonstrating difficulties in collecting accurate information. Non-adherence rates range from 4% to 94% (Martins et al, 2017;Meichenbaum & Turk, 2012), with the consensus ranging from 30% to 50% or 60% in long-term, chronic disease-related prescriptions (Coelho et al, 2017;Haynes et al, 1979;Martins et al, 2017;WHO, 2003). In therapeutic regimens, these rates vary between 30% and 40%.…”

Section: Introductionmentioning

confidence: 99%

“…In arterial hypertension (AH), about 50% of patients do not adhere to the proposed treatment (e.g., adequate diet, exercise, stress management, medication). In HIV (human immunodeficiency virus) infections, adherence rates are higher than 50% (Meichenbaum & Turk, 2012), while, at some point, 44% of transplant patients do not take immunosuppressive therapy (Coelho et al, 2017). In psychiatry, 51% to 85% of patients with schizophrenia do not adhere to treatment (Gorczynski et al, 2017), as well as 9% to 57% of those with bipolar disorder (Meichenbaum & Turk, 2012).…”

Section: Introductionmentioning

confidence: 99%

“…(Meichenbaum & Turk, 2012). Evidence shows that the first year is the most critical period for deciding whether or not to continue treatment (Coelho et al, 2017). More than 50% of patients discontinue treatment during this period, most of whom do so within the first 3 months.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Adesão terapêutica: contributos para a compreensão e intervenção

Camarneiro¹

2021

Rev. Enf. Ref.

View full text Add to dashboard Cite

Background: Therapeutic adherence (TA) aims to improve the health of individuals and populations. It is highly complex and influenced by multiple factors. Non-adherence rates are still excessively high, and it is important to know more about them to intervene. Objectives: To analyze concepts of TA, reflect on factors associated with TA, systematize intervention strategies, and understand assessment methods. Main topics under analysis: As part of patient behavior, TA is the expected outcome of health professionals' recommendations/prescriptions, following mutual cooperation. Patient motivation is essential to overcome barriers to behavioral change, and patients are considered co-responsible for their treatment. Health professionals adopt TA promotion strategies to benefit and mobilize users. Health services and policies support the minimization of obstacles and encourage the evaluation of TA to improve practices. Conclusion: TA is multifactorial, which makes the process more difficult. Successful TA requires coordinating all involved stakeholders -users, health professionals, and social and political bodies, by anticipating the appropriate measures.

show abstract

Investigação sobre adesão à terapêutica na população portuguesa: uma revisão de âmbito

Cited by 2 publications

References 28 publications

Potential drug therapy problems: identification and associated factors among Primary Health Care users

Potential drug therapy problems: identification and associated factors among Primary Health Care users

Adesão terapêutica: contributos para a compreensão e intervenção

Contact Info

Product

Resources

About